Subscribe
23 May 2018Americas

DowDuPont unit and Monsanto sign insect licensing deal

Corteva Agriscience, the agriculture division of DowDuPont, has signed a licensing deal with Monsanto to use its technology for fighting insects found on corn.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Bayer makes $62bn Monsanto bid
24 May 2016   Pharmaceutical company Bayer has revealed that it is offering to buy Monsanto for $62 billion.
Americas
Monsanto enters into CRISPR/Cas licensing deal
28 September 2016   Agrochemical company Monsanto has entered into a global licensing agreement with the Broad Institute of MIT and Harvard to use the CRISPR/Cas genome-editing technology in agriculture.
Americas
Bayer-Monsanto deal: US gov orders largest-ever merger divestiture
30 May 2018   The US government has required German company Bayer to divest $9 billion worth of business and assets in order to continue with its proposed $66 billion acquisition of US-based Monsanto.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Big Pharma
Bayer makes $62bn Monsanto bid
24 May 2016   Pharmaceutical company Bayer has revealed that it is offering to buy Monsanto for $62 billion.
Americas
Monsanto enters into CRISPR/Cas licensing deal
28 September 2016   Agrochemical company Monsanto has entered into a global licensing agreement with the Broad Institute of MIT and Harvard to use the CRISPR/Cas genome-editing technology in agriculture.
Americas
Bayer-Monsanto deal: US gov orders largest-ever merger divestiture
30 May 2018   The US government has required German company Bayer to divest $9 billion worth of business and assets in order to continue with its proposed $66 billion acquisition of US-based Monsanto.

More on this story

Big Pharma
Bayer makes $62bn Monsanto bid
24 May 2016   Pharmaceutical company Bayer has revealed that it is offering to buy Monsanto for $62 billion.
Americas
Monsanto enters into CRISPR/Cas licensing deal
28 September 2016   Agrochemical company Monsanto has entered into a global licensing agreement with the Broad Institute of MIT and Harvard to use the CRISPR/Cas genome-editing technology in agriculture.
Americas
Bayer-Monsanto deal: US gov orders largest-ever merger divestiture
30 May 2018   The US government has required German company Bayer to divest $9 billion worth of business and assets in order to continue with its proposed $66 billion acquisition of US-based Monsanto.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Attorney v examiner: Navigating patenting's AI tools ‘arms race’
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool